Literature DB >> 7548236

Plasma cholesterol esterase level is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects.

J Brodt-Eppley1, P White, S Jenkins, D Y Hui.   

Abstract

Plasma cholesterol level is controlled by various factors. In the present study, high plasma activity of cholesterol esterase was found to correlate with plasma total cholesterol and low density lipoprotein (LDL) cholesterol levels in normolipidemic human subjects. However, the cholesterol esterase is not elevated in plasma of patients with familial hypercholesterolemia. These observations suggest that cholesterol esterase level is not determined by plasma cholesterol level, but elevated cholesterol esterase may be causative in increasing plasma cholesterol and LDL. Additional experiments further demonstrated that cholesterol esterase can convert the larger and less-atherogenic LDL to the smaller and more atherogenic LDL subspecies in vitro. These results suggest that plasma cholesterol esterase contributes to the formation and accumulation of atherogenic lipoproteins, and thus is a major risk factor for premature atherosclerosis in normal human subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548236     DOI: 10.1016/0925-4439(95)00083-g

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

2.  New insights in the activation of human cholesterol esterase to design potent anti-cholesterol drugs.

Authors:  Shalini John; Sundarapandian Thangapandian; Prettina Lazar; Minky Son; Chanin Park; Keun Woo Lee
Journal:  Mol Divers       Date:  2013-10-31       Impact factor: 2.943

3.  Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.

Authors:  Ling Li; Wei Weng; Earl H Harrison; Edward A Fisher
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

4.  Molecular modeling of the structures of human and rat pancreatic cholesterol esterases.

Authors:  S R Feaster; D M Quinn; B L Barnett
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

5.  Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as conformationally constrained inhibitors of cholesterol esterase.

Authors:  Ming-Cheng Lin; Gin-Zen Lin; Ching-In Hwang; Shuo-Yung Jian; James Lin; Yu-Fong Shen; Gialih Lin
Journal:  Protein Sci       Date:  2012-08-09       Impact factor: 6.725

6.  Stereoselective inhibition of cholesterol esterase by enantiomers of exo- and endo-2-norbornyl-N-n-butylcarbamates.

Authors:  Ming-Cheng Lin; Shyh-Jei Yeh; I-Ru Chen; Gialih Lin
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

7.  Localization of carboxyl ester lipase in human pituitary gland and pituitary adenomas.

Authors:  Stefano La Rosa; Davide Vigetti; Claudia Placidi; Giovanna Finzi; Silvia Uccella; Moira Clerici; Barbara Bartolini; Ileana Carnevali; Marco Losa; Carlo Capella
Journal:  J Histochem Cytochem       Date:  2010-06-21       Impact factor: 2.479

8.  Reverse cholesterol transport is elevated in carboxyl ester lipase-knockout mice.

Authors:  Lisa M Camarota; Laura A Woollett; Philip N Howles
Journal:  FASEB J       Date:  2011-01-06       Impact factor: 5.191

9.  Synthesis and secretion of the pancreatic-type carboxyl ester lipase by human endothelial cells.

Authors:  F Li; D Y Hui
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

10.  Benzene-di-N-substituted carbamates as conformationally constrained substrate analogs of cholesterol esterase.

Authors:  S-Y Chiou; M-C Lin; M-T Hwang; H-G Chang; G Lin
Journal:  Protein J       Date:  2008-08       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.